Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coffee Bioequivalence Trial: Comparing the Pharmacokinetics of Bioactive Components and Physiological Effects of Consuming Encapsulated Instant Coffee Versus Traditional Instant Coffee Brewed in Water

NCT06758531 is registered in ClinicalTrials.gov with University of Reading as lead sponsor.

NCT NCT06758531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06758531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coffee Bioequivalence Trial: Comparing the Pharmacokinetics of Bioactive Components and Physiological Effects of Consuming Encapsulated Instant Coffee Versus Traditional Instant Coffee Brewed in Water
Lead sponsor
University of Reading
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
December 30, 2025
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalence, cardiometabolic risk markers, cardiovascular risk, liver functions